SCRMP-mediated SUMOylation of CSNK2B facilitates DNA damage repair to promote cisplatin resistance in small cell lung cancer.

Chen Y, Chen Q, Guo J, Li Z, Yu S, Huang P, Ke X, Shi X, Sun M, Nie F, Liu X

Open source

DOI
10.1126/scitranslmed.aea5653
Published
2026 Sep 23
Container
Science translational medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1126/scitranslmed.aea5653,
  title = {SCRMP-mediated SUMOylation of CSNK2B facilitates DNA damage repair to promote cisplatin resistance in small cell lung cancer.},
  author = {Chen Y and Chen Q and Guo J and Li Z and Yu S and Huang P and Ke X and Shi X and Sun M and Nie F and Liu X},
  year = {2026},
  journal = {Science translational medicine},
  doi = {10.1126/scitranslmed.aea5653},
  url = {https://doi.org/10.1126/scitranslmed.aea5653}
}

RIS

TY  - JOUR
TI  - SCRMP-mediated SUMOylation of CSNK2B facilitates DNA damage repair to promote cisplatin resistance in small cell lung cancer.
AU  - Chen Y
AU  - Chen Q
AU  - Guo J
AU  - Li Z
AU  - Yu S
AU  - Huang P
AU  - Ke X
AU  - Shi X
AU  - Sun M
AU  - Nie F
AU  - Liu X
PY  - 2026
JO  - Science translational medicine
DO  - 10.1126/scitranslmed.aea5653
UR  - https://doi.org/10.1126/scitranslmed.aea5653
ER  - 

APA

Y, C., Q, C., J, G., Z, L., S, Y., P, H., X, K., X, S., M, S., F, N., & X, L. (2026). SCRMP-mediated SUMOylation of CSNK2B facilitates DNA damage repair to promote cisplatin resistance in small cell lung cancer.. Science translational medicine. https://doi.org/10.1126/scitranslmed.aea5653

Source records